Contained Aortic Rupture as a Late Complication of Transcutaneous Aortic Valve Implantation  by Kumar, Abhishek et al.
IC
T
A
S
R
B
T
a
p
V
(
f
s
l
O
f
(
(
w
fi
m
F
c
n
c

r
C
p
a
v
c
W
t
n
i
m
F
p
C
R
F
t
M
F
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 3 , N O . 8 , 2 0 1 0
© 2 0 1 0 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 9 8 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c i n . 2 0 1 0 . 0 2 . 0 1 3MAGES IN INTERVENTION
ontained Aortic Rupture as a Late Complication of
ranscutaneous Aortic Valve Implantation
bhishek Kumar, MBBS,* Jerzy Wojciuk,* Kenneth P. Morgan, MBCHB,*
ohail Khan, MBCHB,* Ranjit S. More, MBCHB,* Franco Sogliani, MD,†
oger W. Bury, MBCHB,‡ David H. Roberts, MD*
lackpool, United Kingdoma
d
t
i
t
c
c
e
w
l
m
e
a
c
o
aranscutaneous aortic valve implantation (TAVI) is
n effective treatment strategy for aortic stenosis in
atients deemed unfit for conventional surgery (1).
arious complications of TAVI have been reported
2–4); however, aortic rupture leading to hematoma
ormation acting as a source of sepsis, is unreported.
A 77-year-old man with severe symptomatic aortic
tenosis, moderate left ventricular dysfunction, and
ogistic EuroSCORE (European System for Cardiac
perative Risk Evaluation) of 11.25% had a success-
ul TAVI with 29-mm CoreValve prosthesis
Medtronic CoreValve, Minneapolis, Minnesota) (4)
Fig. 1). He was discharged on a combination of
arfarin and clopidogrel as he had chronic atrial
brillation and recent non–ST-segment elevation
yocardial infarction treated with bare-metal stents.
our months after TAVI, he was admitted with
onfusion, weight loss, and microcytic anemia. Sig-
ificant findings on investigations: multiple blood
ultures positive for Staphylococcus epidermidis, a 4.3-
-4.1-cm pseudoaneurysm at superior pericardial
ecess due to aortic rupture at the superior edge of the
oreValve visualized on cardiac computed tomogra-
hy (Figs. 2A to 2C) and confirmed by transesoph-
geal echocardiogram (Fig. 3, Online Video 1). No
egetations were noted. The pseudoaneurysm was
onsidered to be the most likely source of sepsis.
arfarin was discontinued, and the patient was
reated conservatively with rifampicin and intrave-
ous vancomycin. Initially, the patient seemed to
mprove; however, days later, he passed away due to
ultiorgan failure secondary to sepsis.
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ebruary 8, 2010, accepted February 21, 2010.In this case, it is likely that a small tear occurred
t the superior edge of the CoreValve prosthesis
uring the procedure that led to the formation of
he pseudoaneurysm, which probably became
nfected over a period of time. This was poten-
ially aggravated by the influence of warfarin and
lopidogrel.
This case not only illustrates an unreported late
omplication of TAVI, but it also raises the issue of
ffective anticoagulation strategy in TAVI patients
ith complications (chronic atrial fibrillation and
eft ventricular dysfunction) as well as the issue of
anagement of contained aortic ruptures. In gen-
ral, these patients have significant comorbidities,
nd they are at high risk of bleeding. Further, these
ontained sites of rupture might act as a nidus of
ngoing sepsis and treatment with conventional
ntibiotic regimen alone may not be effective.
Figure 1. Immediate Post-TAVI Implantation TEE
Mid-esophageal long-axis transesophageal echocardiographic
(TEE) image taken immediately after transcutaneous aortic
valve implantation (TAVI). Arrowheads indicate placement of
CoreValve stent. The dotted area is the sinus of Valsalva. As
Ao  ascending aorta; CVL  CoreValve leaﬂet; LVOT  left
ventricular outﬂow tract; SV  sinus of Valsalva.
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other abbreviations as in Figure 1.
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APPENDIX
Figure 3. TEE 4 Months After Implantation
Transesophageal echocardiographic image (mid-esophageal long-axis) 4
months after transcutaneous aortic valve implantation (Online Video 1).
Dotted area indicates the pseudoaneurysm. Ao  aorta; CVL  CoreValve
leaﬂet; other abbreviations as in Figures 1 and 2.Figure 2. Thoracic CT Study
Thoracic computed tomography (CT) study with contrast demonstrating
small pseudoaneurysm (arrow) from the ascending aorta extending behind
the CoreValve device (*). (A) Inﬂow-outﬂow plane; (B) axial-oblique plane;
(C) sagittal-oblique plane volume-rendered technique. Small arrowheads
in (B) delineate the CoreValve device. LA  left atrium; LV  left ventricle;or an accompanying video, please see online version of this article.
